|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 3181 S.W. SAM JACKSON PARK ROAD |
Address2 | |
City | PORTLAND |
State | OR |
Zip Code | 97239 |
Country | USA |
3. Principal place of business (if different than line 2)
City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 30291-12
|
||||||||
|
6. House ID# 319460000
|
TYPE OF REPORT | 8. Year | 2010 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Steve Stadum, Executive VP |
Date | 04/20/2010 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Improving Health Insurance Coverage: "Healthy Americans Act" (S 391), "Patient Protection and Affordable Health Care Act" (HR 3590), "Affordable Health Care for America Act" (HR 3962); Health Care and Education Affordability Reconciliation Act of 2010" (HR 4872); Health Professions Shortages Including Capitation Grants for Nursing Schools: "Nurse Education, Expansion and Development Act" (S 497/HR 2043);
Expanding Comparative Effectiveness Research: "Comparative Effectiveness Research Act of 2009" (HR 2502), "Patient-Centered Outcomes Research Act of 2009" (S 1213), "Affordable Health Care for America Act," Division B; Subtitle A of Division B, Title VIII (HR 3962), "Patient Protection and Affordable Care Act," Title VI, Subtitle D (HR 3590); Follow-on Biologics: "Pathway for Biosimilars Act of 2009" (HR 1548); Inclusion of Academic Health Centers in Health Care Reform Through the Creation of Healthcare Innovation Zones (HR 3134); Provider Reimbursements Associated With Expansion of Health Insurance Coverage; Reauthorization of health profession education programs under Title VI and Title VIII of the Public Health Service Act, the Reauthorization of NIH Health Service Corps and Health Professional Shortage Areas designation criteria methodology: "Patient Protection and Affordable Care Act," Title V (HR 3590).
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Lynne |
Boyle |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
Discounted Drug Prices for 340B Hospitals: Section 340B of the Public Health Services Act (HR 444/S 1239), "Affordable Health Care for America Act" Division C, Title V, Subtitle A (HR 3962), "Patient Protection and Affordable Care Act" Title VII, Subtitle B, Section 7101 (HR 3590).
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Lynne |
Boyle |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
FY2011 funding for NIH and Rare Disease Research such as Neurodegeneration with Brain Iron Accumulation, Title VII and VII of the Public Health Services Act, National Health Service Corporation, Centers for Disease Control, National Science Foundation, Agency for Healthcare Research and Quality and Primary Care Research Networks, Prevention and Education Programs to Prevent Youth Athletes from Using Steroids, Oregon Center Translational Genomics,
Multidisciplinary Institute for Neuropsychiatric Diagnosis, Interprofessional Health Curriculum Development, Oregon Center for Aging and Technology, Oregon Translational Research and Drug Development Institute, Oregon Nanoscience and Microtechnologies Institute, South Waterfront District Energy study and Oregon Bioscience Entrepreneur Center.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS), Natl Institutes of Health (NIH), Office of Natl Drug Control Policy (NDCP), Vice President of the U.S., Substance Abuse & Mental Health Services Administration (SAMHSA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Lynne |
Boyle |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CPT
16. Specific lobbying issues
Preserve intellectual property rights for medical schools and teaching hospitals: "Patent Reform Act of 2009" (H.R. 1260/S. 515).
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Lynne |
Boyle |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ANI
16. Specific lobbying issues
Use of chimpanzees in biomedical reserach: "Great Ape Protection Act" (HR 1326).
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Lynne |
Boyle |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Increasing Medicare's Resident Limits: "Resident Physician Shortage Reduction Act of 2009" ( S 973/HR 2251); Provider Reimbursement for End of Life Care Counseling: Life Care Sustaining Treatment Preferences Act of 2009 (HR 1898), "Affordable Health Care for America Act, Div. B, Title II; Subtitle C, Section 1233 (HR 3962);
Medicare Reimbursement for use of Shared Decision-Making Tools": (HR 2580/S 1133), "Affordable Health Care for America Act", Div. B, Title II, Subtitle C, Section 1236 (HR 3962); Medicare Physician Payments: Averting a 21% Reduction in CY 2010: "Patient Protection and Affordable Care Act" (HR 3590), "Medicare Physician Fairness Act of 2009" (S 1776), "Medicare Physician Payment Reform Act of 2009" (HR 3961) "Continuing Extension Act of 2010" (HR 4851); Maintaining Operating Indirect Medical Education Payments: "Patient Protection and Affordable Care Act" Title V (HR 3590), "Affordable Health Care for America Act" Division B, Title V; Preventing Cuts to Medicare and Medicaid Disproportionate Share Hospital Payments: "Patient Protection and Affordable Care Act," Title II, Subtitle G and Title III, Subtitle B, Part III (HR 3590), Affordable Health Care for America Act, Division B, Title I, Subtitle A, Part II and Division B, Title VII, Subtitle A (HR 3962) "Health Care and Education Affordability Reconciliation Act of 2010 (HR 4872); Preventing Reductions to Medicare Inpatient and Outpatient Payment Rate Updates: "Patient Protection and Affordable Care Act," Title III, Subtitle B, Part III (HR 3590), Affordable Health Care for America Act Division B, Title I (HR 3962), "Health Care and Education Affordability Reconciliation Act of 2010" (HR 4872); Medicare support for Nurse Training: Medicare Graduate Nursing Education Act (HR 3185/S1569), Affordable Health Care for America Act" Title V, Subtitle F (HR 3590); Geographic Variations in Medicare Payments: Affordable Health Care for America Act Division B, Title I, Subtitles B and C (HR 3962), "Patient Protection and Affordable Care Act" Title III (HR 3950), "Health Care and Education Affordability Reconciliation Act of 2010 (HR 4872); Establishment of Independent Medicare advisory Commission:"Patient Protection and Affordable Care Act" Title III, Subtitle E (HR 3590), "Health Care and Education Affordability Reconciliation Act of 2010 (HR 4872); Medicare and Medicaid Health IT Incentive Payments Proposed Rule:"Continuing Extension Act of 2010" (HR 4851); Extension of ARRA Medicaid Federal Matching Assistance Program: "American workers, State and Business Relief Act of 2010" (HR 4213); Medicare payments for clinical laboratories: "Affordable Health Care for America Act" (HR 3590).
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Lynne |
Boyle |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |